Warning: The NCBI web site requires JavaScript to function. more...
Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.
White NJ, Pongtavornpinyo W, Maude RJ, Saralamba S, Aguas R, Stepniewska K, Lee SJ, Dondorp AM, White LJ, Day NP.
Malar J. 2009 Nov 11;8:253.
Related citations
The de novo selection of drug-resistant malaria parasites.
White NJ, Pongtavornpinyo W.
Proc Biol Sci. 2003 Mar 7;270(1514):545-54.
Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.
Pongtavornpinyo W, Yeung S, Hastings IM, Dondorp AM, Day NP, White NJ.
Malar J. 2008 Nov 2;7:229.
[Combined antimalarial therapy using artemisinin].
Majori G.
Parassitologia. 2004 Jun;46(1-2):85-7. Review. Italian.
Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty.
Smith DL, Klein EY, McKenzie FE, Laxminarayan R.
Malar J. 2010 Jul 23;9:217.
Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.
Malar J. 2009 Jan 5;8:2.
Drug resistance among malaria and other parasites.
Barat LM, Bloland PB.
Infect Dis Clin North Am. 1997 Dec;11(4):969-87. Review.
The role of anti-malarial drugs in eliminating malaria.
White NJ.
Malar J. 2008 Dec 11;7 Suppl 1:S8. Review.
Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.
Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana CO, Heymann DL, Breman JG.
Am J Trop Med Hyg. 1996;55(1 Suppl):24-32.
Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance.
Alexander N, Sutherland C, Roper C, Cissé B, Schellenberg D.
Malar J. 2007 Jan 22;6:9.
[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.
Sante. 2008 Jan-Mar;18(1):43-7. French.
Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.
Simpson JA, Watkins ER, Price RN, Aarons L, Kyle DE, White NJ.
Antimicrob Agents Chemother. 2000 Dec;44(12):3414-24.
A research agenda for malaria eradication: drugs.
malERA Consultative Group on Drugs.
PLoS Med. 2011 Jan 25;8(1):e1000402. Review.
Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria.
Congpuong K, Bualombai P, Banmairuroi V, Na-Bangchang K.
Malar J. 2010 Feb 4;9:43.
Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
Stepniewska K, White NJ.
Antimicrob Agents Chemother. 2008 May;52(5):1589-96. Epub 2008 Feb 25.
Molecular epidemiology of malaria in cameroon. IX. Characteristics of recrudescent and persistent Plasmodium falciparum infections after chloroquine or amodiaquine treatment in children.
Basco LK, Ndounga M, Keundjian A, Ringwald P.
Am J Trop Med Hyg. 2002 Feb;66(2):117-23.
Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes.
Drakeley CJ, Jawara M, Targett GA, Walraven G, Obisike U, Coleman R, Pinder M, Sutherland CJ.
Trop Med Int Health. 2004 Jan;9(1):53-61.
Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
Barnes KI, White NJ.
Acta Trop. 2005 Jun;94(3):230-40. Review.
Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo.
Vivas L, Rattray L, Stewart L, Bongard E, Robinson BL, Peters W, Croft SL.
Acta Trop. 2008 Mar;105(3):222-8. Epub 2007 Dec 23.
UK malaria treatment guidelines.
Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, Hill DR, Warrell DA, Bannister BA; HPA Advisory Committee on Malaria Prevention in UK Travellers.
J Infect. 2007 Feb;54(2):111-21. Epub 2007 Jan 9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on